Conferences and symposiums Inauguration Symposium for Theranostics Trial Center
Theranostics: Multidisciplinary Insights and Future Directions
You are here invited to an Inauguration Symposium for Theranostics Trial Center. Welcome!
Target audience: Scientists, researchers, clinicians, policymakers, regulatory agents, patient representatives
Purpose: to provide a current state-of-the-art, inspiring future glimpse of new developments in the field of radiopharmaceuticals and showcase activities within the TTC.
The upcoming symposium will bring together national and international experts in the field of onco-theranostics, including pre-clinical and translational researchers, nuclear medicine specialists, oncologists, radiologists, medical physicists and representatives of Swedish pharmaceutical companies, patient organizations and decision-makers. Topics include advancements in targeting substances for diagnostic and therapeutic purposes, dosimetry, whole-body PET, and clinical applications. See the program below
The symposium is free of charge. Register to secure your attendance and submit abstract for poster session.
Preliminary program
From 8.30 Coffee, registration
9.00-9.15 Welcome
Rimma Axelsson, Professor Nuclear Medicine, Founder of TTC
Mathias Axelsson, Head of Medical Diagnostics Karolinska University Hospital
Lars Holmgren, Professor and Head of Department of Oncology-Pathology
9.20-10.00 State-of-the-art overview of theranostics: use in clinical practice and ongoing trials
Désirée Deandreis, Professor, chief of the nuclear medicine division at Gustave Roussy and University of Turin, France
10.00-10.30 Coffee and posters
10.30-11.00 Development of protein-based theranostic pairs from an industrial perspective
Fredrik Frejd, Professor Uppsala University and CFO Affibody AB Sweden.
11.00-11.15 Theranostic trials in pediatric oncology
Jakob Stenman, Associate professor Karolinska Institutet and Pediatric surgeon at Karolinska University Hospital, Stockholm, Sweden
11.15 -11.30 Starting early-stage clinical trials with radiopharmaceuticals
Renske Altena, Associate professor, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
11.30-12.30 Lunch and posters
12.30-13.00 Physicist perspective – dosimetry of new radiotheranostic products
Caroline Stokke, Professor and Head of Nuclear Medicine & PET Physics, Oslo University Hospital, Norway
13.00- 13.30 At-221 and beyond
Stig Palm, Associate professor, Department of Radiation Physics, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
13.30-14.00 Advances and future perspectives of 161-Tb-labelled radiopharmaceuticals.
Christina Müller, Professor Paul Scherrer Institute, Center for Radiopharmaceutical Sciences, Switzerland
14.00-14.30 Coffee and poster
14.30-15.15 New possibilities with whole body PET-cameras
Adrienne H Brouwers, Professor Department of Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, The Netherlands
15.15-16.00 Panel Discussion
16.00-16.15 Concluding Remarks and Poster Prize